Outcome After Failure of Second Generation Tyrosine Kinase Inhibitors Treatment As First-line Therapy for Patients With Chronic Myeloid Leukemia

INTRODUCTION: The outcome of patients with CML who discontinue 2G-TKI initial therapy is unknown. We analyzed the characteristics of patients in whom treatment with first-line 2G-TKIs had failed. PATIENTS AND METHODS: A total of 218 patients with CML were treated with dasatinib (n = 101) or nilotini...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Eghtedar, Alireza, Kantarjian, Hagop, Jabbour, Elias, O’Brien, Susan, Burton, Elizabeth, Garcia-Manero, Guillermo, Verstovsek, Srdan, Ravandi, Farhad, Borthakur, Gautam, Konopleva, Marina, Quintas-Cardama, Alfonso, Cortes, Jorge
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3752280/
https://ncbi.nlm.nih.gov/pubmed/23770156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2013.02.025
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars